Screener
IBB vs IXJ
iShares Biotechnology ETF vs iShares Global Healthcare ETF
Key differences
- Over the last 3 years, IBB has delivered higher annualized returns.
Side-by-side comparison
| IBB | IXJ | |
|---|---|---|
| Annual cost (TER) | 0.44% | 0.40% |
| Fund size (AUM) | $7.9B | $3.6B |
| Since | 2001 | 2001 |
| Dividend yield | 0.23% | 1.46% |
| Asset class | equity | equity |
| Region | north america | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +39.0% | +13.6% |
| CAGR 3Y | +9.6% | +5.1% |
| CAGR 5Y | +2.7% | +4.6% |
| Sharpe 3Y | 0.38 | 0.17 |
| Volatility 1Y | 19.75% | 14.45% |
| Max drawdown | -39.82% | -27.35% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IBB and IXJ
Explore further